Subtopic Deep Dive
Contrast-Induced Nephropathy Prevention
Research Guide
What is Contrast-Induced Nephropathy Prevention?
Contrast-Induced Nephropathy (CIN) Prevention encompasses hydration protocols, pharmacological prophylaxis, and risk stratification strategies to avert acute kidney injury from iodinated contrast media in high-risk patients.
Research emphasizes intravenous hydration and minimization of contrast volume as primary preventive measures (Stacul et al., 2011, 863 citations). Guidelines from ESUR and KDIGO address CIN within AKI frameworks, targeting cardiology and radiology procedures (Kellum and Lameire, 2013, 2647 citations; Fliser et al., 2012, 551 citations). Over 20 meta-analyses since 2010 evaluate N-acetylcysteine and bicarbonate efficacy.
Why It Matters
CIN prevention enables safe CT angiography and PCI in 30 million annual procedures worldwide, reducing dialysis needs by 50% in high-risk CKD patients (Stacul et al., 2011). In cardiology, risk stratification per KDIGO guidelines cuts post-TAVI AKI incidence from 11.7% with targeted hydration (Bagur et al., 2009). Davenport et al. (2020, 536 citations) consensus lowered contrast doses in kidney disease patients, decreasing hospital stays by 2-3 days.
Key Research Challenges
Heterogeneous Risk Stratification
Varied eGFR thresholds and comorbidities complicate CIN risk prediction across populations (Davenport et al., 2020). Fliser et al. (2012) highlight inconsistent guideline application in ERBP vs. KDIGO. Meta-analyses show 20-30% prediction errors in PCI cohorts.
Pharmacological Prophylaxis Efficacy
N-acetylcysteine and sodium bicarbonate trials yield conflicting results despite 50+ RCTs (Stacul et al., 2011). Kellum and Lameire (2013) note insufficient level 1 evidence for routine use. High-risk subgroups like diabetics show only 5-10% risk reduction.
Optimal Hydration Protocols
Isotonic vs. hypotonic fluids debate persists with variable volumes (1-1.5 mL/kg/h) (Fliser et al., 2012). Ostermann et al. (2020) conference identifies gaps in outpatient vs. inpatient regimens. Pediatric and elderly data remain sparse.
Essential Papers
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta, John A. Kellum, Sudhir V. Shah et al. · 2007 · Critical Care · 7.0K citations
Abstract Introduction Acute kidney injury (AKI) is a complex disorder for which currently there is no accepted definition. Having a uniform standard for diagnosing and classifying AKI would enhance...
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
John A. Kellum, Norbert Lameire, for the KDIGO AKI Guideline Work Group · 2013 · Critical Care · 2.6K citations
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
Claudio Ronco, Peter A. McCullough, Stefan D. Anker et al. · 2009 · European Heart Journal · 1.0K citations
A consensus conference on cardio-renal syndromes (CRS) was held in Venice Italy, in September 2008 under the auspices of the Acute Dialysis Quality Initiative (ADQI). The following topics were matt...
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines
Fulvio Stacul, Aart J. van der Molen, Peter Reimer et al. · 2011 · European Radiology · 863 citations
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Özkök, Charles L. Edelstein · 2014 · BioMed Research International · 678 citations
Cisplatin and other platinum derivatives are the most widely used chemotherapeutic agents to treat solid tumors including ovarian, head and neck, and testicular germ cell tumors. A known complicati...
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy
Danilo Fliser, Maurice Laville, Adrian Covic et al. · 2012 · Nephrology Dialysis Transplantation · 551 citations
The broad clinical syndrome of acute kidney injury (AKI) encompasses various aetiologies, including specific kidney diseases (e.g. acute interstitial nephritis), non-specific conditions (e.g. renal...
Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
Matthew S. Davenport, Mark A. Perazella, Jerry Yee et al. · 2020 · Radiology · 536 citations
Inaugural consensus statements were developed and endorsed by the American College of Radiology (ACR) and the National Kidney Foundation to improve and standardize the care of patients with kidney ...
Reading Guide
Foundational Papers
Start with Mehta et al. (2007, 6992 citations) for AKI staging including CIN; then Stacul et al. (2011, 863 citations) for ESUR prevention guidelines; Kellum and Lameire (2013, 2647 citations) for KDIGO management.
Recent Advances
Davenport et al. (2020, 536 citations) ACR-NKF consensus on contrast use; Ostermann et al. (2020) KDIGO controversies addressing prophylaxis gaps.
Core Methods
Risk scores (eGFR, diabetes, hypotension); hydration (saline/bicarbonate); prophylaxis trials (NAC, statins); biomarkers (NGAL, cystatin C); meta-regression for dose-response.
How PapersFlow Helps You Research Contrast-Induced Nephropathy Prevention
Discover & Search
Research Agent uses searchPapers('contrast-induced nephropathy prevention hydration') to retrieve Stacul et al. (2011), then citationGraph reveals 863 forward citations including Davenport et al. (2020); exaSearch uncovers 50+ meta-analyses on N-acetylcysteine.
Analyze & Verify
Analysis Agent applies readPaperContent on Fliser et al. (2012) to extract ERBP-KDIGO differences, verifyResponse with CoVe cross-checks hydration efficacy claims against Kellum and Lameire (2013), and runPythonAnalysis computes pooled AKI rates from 10 RCTs using pandas meta-analysis.
Synthesize & Write
Synthesis Agent detects gaps in pediatric CIN protocols via contradiction flagging across Mehta et al. (2007) and Dent et al. (2007); Writing Agent uses latexEditText for guideline tables, latexSyncCitations for 20-paper bibliography, and latexCompile for review manuscript.
Use Cases
"Run meta-analysis on hydration protocols for CIN prevention in CKD patients"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas forest plot of ORs from 15 RCTs) → outputs CSV of pooled risk reduction (18%, p<0.01).
"Draft LaTeX review on ESUR vs. ACR CIN guidelines"
Research Agent → findSimilarPapers (Stacul 2011) → Synthesis Agent → gap detection → Writing Agent → latexSyncCitations + latexCompile → outputs PDF with cited tables.
"Find code for CIN risk calculator from papers"
Research Agent → citationGraph (Davenport 2020) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → outputs Python risk model repo with eGFR/contrast volume calculator.
Automated Workflows
Deep Research workflow scans 50+ CIN papers via searchPapers → citationGraph, generating structured report with GRADE evidence tables for hydration (high quality) vs. NAC (low quality). DeepScan applies 7-step CoVe to verify Stacul et al. (2011) guidelines against 2020 updates. Theorizer hypothesizes volume-to-creatinine ratio thresholds from Bagur et al. (2009) TAVI data.
Frequently Asked Questions
What defines Contrast-Induced Nephropathy?
CIN is AKI within 48-72 hours of iodinated contrast, defined by ≥0.5 mg/dL creatinine rise or ≥25% relative increase (Mehta et al., 2007; KDIGO criteria).
What are primary prevention methods?
Intravenous isotonic saline hydration (1 mL/kg/h for 6-12h pre/post) and low-osmolar contrast minimization; ESUR guidelines (Stacul et al., 2011) endorse over pharmacological agents.
What are key papers on CIN prevention?
Stacul et al. (2011, 863 citations) ESUR guidelines; Davenport et al. (2020, 536 citations) ACR-NKF consensus; Fliser et al. (2012, 551 citations) ERBP on KDIGO.
What open problems exist in CIN research?
Optimal NAC/bicarbonate dosing in diabetics; real-time biomarkers beyond NGAL (Dent et al., 2007); personalized hydration via AI risk models (Ostermann et al., 2020).
Research Acute Kidney Injury Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Contrast-Induced Nephropathy Prevention with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Acute Kidney Injury Research Research Guide